Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Conventional), Infection Type (UTI, Pneumonia), Product (Consumables), Type, Region, and Segment Forecasts, 2023-2030

The global hospital acquired infections diagnostics market is expected to reach USD 7.15 billion by 2030, according to the report. The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR of 7.2% during the period of 2023 to 2030. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2015 to 2022.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Hospital Acquired Infections Diagnostics Market Report Highlights

The consumables segment held the largest revenue share of 63.5% in the hospital acquired infections diagnostics market in 2022 and is expected to expand at the fastest CAGR of 7.7% over the forecast period, owing to the rising incidence of HAIs.
The blood tests segment accounted for the largest revenue share of 65.8% in 2022 and is expected to advance at the fastest CAGR of 7.08% during the forecast period.
Europe dominated the market and accounted for the largest revenue share of 34.3% in 2022, owing to the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Infection Type
1.1.3. Product
1.1.4. Type
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. Infection Type outlook
2.2.3. Product outlook
2.2.4. Type outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Hospitals Acquired Infections Diagnostics Market: Test Type Estimates & Trend Analysis

4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
4.2. Hospital Acquired Infections Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
4.3. Conventional
4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Molecular
4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hospital Acquired Infections Diagnostics Market: Infection Type Estimates & Trend Analysis

5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
5.2. Hospital Acquired Infections Diagnostics Market: Infection Type Movement & Market Share Analysis, 2022 & 2030
5.3. UTI
5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Pneumonia
5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Surgical Site Infection
5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Blood Stream Infections
5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hospital Acquired Infections Diagnostics Market: Product Estimates & Trend Analysis

6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
6.2. Hospital Acquired Infections Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
6.3. Consumables
6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Instruments
6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis

7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
7.2. Hospital Acquired Infections Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
7.3. Blood Tests
7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Urinalysis
7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.6. Denmark
8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.7. Sweden
8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.8. Norway
8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. BIOMÉRIEUX
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. F. Hoffmann-La Roche Ltd.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Siemens Healthcare Private Limited
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. BD (Becton, Dickinson and Company)
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Hologic, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Meridian Bioscience, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. QIAGEN
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Thermo Fisher Scientific Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Bioscience, Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 U.S. hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 11 Canada hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 12 Canada hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 Europe hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 16 Europe hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 17 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 18 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 20 UK hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 UK hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 22 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 23 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 24 Germany hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Germany hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 26 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 27 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 28 France hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 29 France hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 30 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 31 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Italy hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 33 Italy hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 34 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 35 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Spain hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 37 Spain hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 38 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 39 Spain hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 40 Denmark hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 41 Denmark hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 42 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 43 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Sweden hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 45 Sweden hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 46 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 47 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 48 Norway hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Norway hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 50 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 51 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 52 Asia Pacific hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 53 Asia Pacific hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 54 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 55 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 56 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 57 Japan hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Japan hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 59 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 60 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 China hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 China hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 63 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 64 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 65 India hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 66 India hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 67 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 68 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 69 Australia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 70 Australia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 71 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 72 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 73 Thailand hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 74 Thailand hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 75 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 76 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 77 South Korea hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 78 South Korea hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 79 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 80 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 81 Latin America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 82 Latin America hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 83 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 84 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 85 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 87 Brazil hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 88 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 89 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 90 Mexico hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 91 Mexico hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 92 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 93 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 94 Argentina hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 95 Argentina hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 96 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 97 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 104 South Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 105 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 106 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 111 UAE hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 112 UAE hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 113 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 114 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
Table 115 Kuwait hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 116 Kuwait hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
Table 117 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
Table 118 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Microneedle Instruments systems: market outlook
Fig. 8 Hospital Acquired Infections Diagnostics competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Hospital acquired infections diagnostics market driver impact
Fig. 13 Hospital acquired infections diagnostics market restraint impact
Fig. 14 Hospital acquired infections diagnostics market strategic initiatives analysis
Fig. 15 Hospital acquired infections diagnostics market: Test type movement analysis
Fig. 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
Fig. 17 Molecular market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Conventional market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Hospital acquired infections diagnostics market: Infection type movement analysis
Fig. 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
Fig. 21 UTI market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Surgical site infection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Blood stream infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Hospital acquired infections diagnostics market: Product movement analysis
Fig. 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
Fig. 28 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Hospital acquired infections diagnostics market: Type movement analysis
Fig. 31 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
Fig. 32 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global hospital acquired infections diagnostics market: Regional movement analysis
Fig. 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Profiled

BIOMÉRIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Hologic, Inc.
Meridian Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Bioscience, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	70
Published	November 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 4.07 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.15 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5817EUR$5,950USD£4,859GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6794EUR$6,950USD£5,675GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8750EUR$8,950USD£7,308GBP

Hospital Acquired Infections Diagnostics Market Report Highlights

Table of Contents

Companies Profiled

Methodology

Table Information

Related Topics

Related Reports

Hospital Acquired Infection Control Market Size, Share and Trends Analysis Report by Type (Equipment, Services, Consumables), End-use (Hospitals & ICUs, Ambulatory Surgical and Diagnostic Centers), and Region 2024-2030

Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2025-2030

Healthcare-associated Infectious Disease Diagnostics Market by Product & Service, Disease Type, End-user - Global Forecast 2025-2030

Hospital Acquired Infections Testing Kits Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Hospital Acquired Infection Control - Global Strategic Business Report